ScoreWhy is Tango Therapeutics, Inc. ?
1
With a growth in Net Profit of 17.5%, the company declared Very Positive results in Jun 25
- The company has declared positive results in Jan 70 after 3 consecutive negative quarters
- NET PROFIT(HY) Higher at USD -78.73 MM
2
High Institutional Holdings at 100%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
3
Market Beating Performance
- The stock has generated a return of 178.16% in the last 1 year, much higher than market (S&P 500) returns of 12.33%
Real-Time Research ReportHow much should you buy?
- Overall Portfolio exposure to Tango Therapeutics, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Tango Therapeutics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
Tango Therapeutics, Inc.
168.29%
0.44
108.37%
S&P 500
13.22%
0.61
20.17%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
124.27%
EBIT Growth (5y)
-435.65%
EBIT to Interest (avg)
-114.87
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.29
Sales to Capital Employed (avg)
0.17
Tax Ratio
0.15%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
2.77
EV to EBIT
-1.70
EV to EBITDA
-1.73
EV to Capital Employed
-5.20
EV to Sales
6.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
-79.32%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend3What is working for the Company
NET PROFIT(HY)
Higher at USD -78.73 MM
-25What is not working for the Company
OPERATING CASH FLOW(Y)
Lowest at USD -148.26 MM
NET PROFIT(HY)
At USD -78.73 MM has Grown at -24.05%
ROCE(HY)
Lowest at -76.09%
DEBT-EQUITY RATIO
(HY)
Highest at -108.34 %
RAW MATERIAL COST(Y)
Grown by 17.19% (YoY
NET SALES(Q)
Lowest at USD 3.18 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -1,268.22 %
Here's what is working for Tango Therapeutics, Inc.
Net Profit
Higher at USD -78.73 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months
Net Profit (USD MM)
Here's what is not working for Tango Therapeutics, Inc.
Net Sales
At USD 3.18 MM has Fallen at -68.96%
over average net sales of the previous four periods of USD 10.25 MMMOJO Watch
Near term sales trend is extremely negative
Net Sales (USD MM)
Operating Cash Flow
Lowest at USD -148.26 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Net Profit
At USD -78.73 MM has Grown at -24.05%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Debt-Equity Ratio
Highest at -108.34 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Net Sales
Lowest at USD 3.18 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (USD MM)
Operating Profit Margin
Lowest at -1,268.22 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Raw Material Cost
Grown by 17.19% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
